HCA Healthcare Inc (HCA) recent activity suggests a positive outlook with the last week’s performance of -4.56%

On Tuesday, HCA Healthcare Inc (NYSE: HCA) was -2.71% down from the session before settling in for the closing price of $322.63. A 52-week range for HCA has been $215.96 – $335.83.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has jumped its sales by 6.95% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 8.37%. With a float of $191.46 million, this company’s outstanding shares have now reached $265.54 million.

In an organization with 310000 employees, it is important to assess its efficiency.

HCA Healthcare Inc (HCA) Insider and Institutional Ownership

Also, it is sometimes useful to examine the sentiment of large-scale investors toward HCA Healthcare Inc stocks. The insider ownership of HCA Healthcare Inc is 27.61%, while institutional ownership is 65.48%. The most recent insider transaction that took place on Mar 20 ’24, was worth 289,299. In this transaction SVP and CIO of this company sold 876 shares at a rate of $330.25, taking the stock ownership to the 1,576 shares. Before that another transaction happened on Mar 18 ’24, when Company’s SVP and CIO sold 344 for $321.97, making the entire transaction worth $110,758. This insider now owns 2,452 shares in total.

HCA Healthcare Inc (HCA) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of 23.66 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 8.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.94% during the next five years compared to 12.21% growth over the previous five years of trading.

HCA Healthcare Inc (NYSE: HCA) Trading Performance Indicators

You can see what HCA Healthcare Inc (HCA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.28. Likewise, its price to free cash flow for the trailing twelve months is 17.71.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 18.98, a number that is poised to hit 5.06 in the next quarter and is forecasted to reach 23.07 in one year’s time.

Technical Analysis of HCA Healthcare Inc (HCA)

Let’s dig in a bit further. During the last 5-days, its volume was 0.95 million. That was inferior than the volume of 1.05 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 11.92%. Additionally, its Average True Range was 6.03.

During the past 100 days, HCA Healthcare Inc’s (HCA) raw stochastic average was set at 75.62%, which indicates a significant increase from 8.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 17.78% in the past 14 days, which was lower than the 20.15% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $319.66, while its 200-day Moving Average is $278.36. However, in the short run, HCA Healthcare Inc’s stock first resistance to watch stands at $320.86. Second resistance stands at $327.84. The third major resistance level sits at $332.32. If the price goes on to break the first support level at $309.41, it is likely to go to the next support level at $304.93. The third support level lies at $297.96 if the price breaches the second support level.

HCA Healthcare Inc (NYSE: HCA) Key Stats

There are 264,485K outstanding shares of the company, which has a market capitalization of 83.02 billion. As of now, sales total 64,968 M while income totals 5,242 M. Its latest quarter income was 17,303 M while its last quarter net income were 1,607 M.